Abstract

The mammalian spermatozoa produced in the testis require functional maturation in the epididymis for their full competence. Epididymal sperm maturation is regulated by lumicrine signalling pathways in which testis-derived secreted signals relocate to the epididymis lumen and promote functional differentiation. However, the detailed mechanisms of lumicrine regulation are unclear. Herein, we demonstrate that a small secreted protein, NELL2-interacting cofactor for lumicrine signalling (NICOL), plays a crucial role in lumicrine signalling in mice. NICOL is expressed in male reproductive organs, including the testis, and forms a complex with the testis-secreted protein NELL2, which is transported transluminally from the testis to the epididymis. Males lacking Nicol are sterile due to impaired NELL2-mediated lumicrine signalling, leading to defective epididymal differentiation and deficient sperm maturation but can be restored by NICOL expression in testicular germ cells. Our results demonstrate how lumicrine signalling regulates epididymal function for successful sperm maturation and male fertility.

Mammalian sperm need to be matured in the epididymis to achieve potential for fertility. Here the authors identify NICOL as a secreted protein that acts on the epididymis to trigger its functional differentiation and induce sperm maturation.

Details

Title
A small secreted protein NICOL regulates lumicrine-mediated sperm maturation and male fertility
Author
Kiyozumi, Daiji 1   VIAFID ORCID Logo  ; Shimada, Kentaro 2 ; Chalick, Michael 3 ; Emori, Chihiro 4   VIAFID ORCID Logo  ; Kodani, Mayo 2 ; Oura, Seiya 2 ; Noda, Taichi 4   VIAFID ORCID Logo  ; Endo, Tsutomu 4   VIAFID ORCID Logo  ; Matzuk, Martin M. 5   VIAFID ORCID Logo  ; Wreschner, Daniel H. 3   VIAFID ORCID Logo  ; Ikawa, Masahito 6   VIAFID ORCID Logo 

 Osaka University, Suita, Research Institute for Microbial Diseases, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); PRESTO, Japan Science and Technology Agency, Kawaguchi, Saitama, Japan (GRID:grid.419082.6) (ISNI:0000 0004 1754 9200) 
 Osaka University, Suita, Research Institute for Microbial Diseases, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); Osaka University, Suita, Graduate School of Pharmaceutical Sciences, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971) 
 Tel Aviv University, Shmunis School for Biomedicine and Cancer Research, Ramat Aviv, Israel (GRID:grid.12136.37) (ISNI:0000 0004 1937 0546) 
 Osaka University, Suita, Research Institute for Microbial Diseases, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971) 
 Baylor College of Medicine, Center for Drug Discovery and Department of Pathology & Immunology, Houston, USA (GRID:grid.39382.33) (ISNI:0000 0001 2160 926X) 
 Osaka University, Suita, Research Institute for Microbial Diseases, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); Osaka University, Suita, Graduate School of Pharmaceutical Sciences, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); Osaka University, Suita, Graduate School of Medicine, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); The University of Tokyo, Minato-ku, The Institute of Medical Science, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); CREST, Japan Science and Technology Agency, Kawaguchi, Saitama, Japan (GRID:grid.419082.6) (ISNI:0000 0004 1754 9200) 
Pages
2354
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2805294298
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.